Associations - CLDN18.2 expression

CLDN18.2 expression CLDN18.2 expression	Esophageal Adenocarcinoma Esophageal Adenocarcinoma	CLDN18.2 expression CLDN18.2 expression	Esophageal Adenocarcinoma Esophageal Adenocarcinoma	IMAB362 Sensitive: C2 – Inclusion Criteria	IMAB362 Sensitive: C2 – Inclusion Criteria
CLDN18.2 expression CLDN18.2 expression	Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma	CLDN18.2 expression CLDN18.2 expression	Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma	IMAB362 Sensitive: C2 – Inclusion Criteria	IMAB362 Sensitive: C2 – Inclusion Criteria
CLDN18.2 expression CLDN18.2 expression	Gastric Adenocarcinoma Gastric Adenocarcinoma	CLDN18.2 expression CLDN18.2 expression	Gastric Adenocarcinoma Gastric Adenocarcinoma	IMAB362 Sensitive: C2 – Inclusion Criteria	IMAB362 Sensitive: C2 – Inclusion Criteria
CLDN18.2 expression CLDN18.2 expression	Gastric Cancer Gastric Cancer	CLDN18.2 expression CLDN18.2 expression	Gastric Cancer Gastric Cancer	Q-1802 Sensitive: C3 – Early Trials	Q-1802 Sensitive: C3 – Early Trials
CLDN18.2 expression CLDN18.2 expression	Pancreatic Cancer Pancreatic Cancer	CLDN18.2 expression CLDN18.2 expression	Pancreatic Cancer Pancreatic Cancer	ZL-1211 Sensitive: D – Preclinical	ZL-1211 Sensitive: D – Preclinical
CLDN18.2 expression CLDN18.2 expression	Gastric Cancer Gastric Cancer	CLDN18.2 expression CLDN18.2 expression	Gastric Cancer Gastric Cancer	ZL-1211 Sensitive: D – Preclinical	ZL-1211 Sensitive: D – Preclinical
CLDN18.2 expression CLDN18.2 expression	Solid Tumor Solid Tumor	CLDN18.2 expression CLDN18.2 expression	Solid Tumor Solid Tumor	TJ-CD4B Sensitive: D – Preclinical	TJ-CD4B Sensitive: D – Preclinical